KTS and RTS-disintegrins:: Anti-angiogenic viper venom peptides specifically targeting the α1β1 integrin

被引:43
作者
Calvete, Juan J.
Marcinkiewicz, Cezary
Sanz, Libia
机构
[1] CSIC, Inst Biomed Valencia, E-46010 Valencia, Spain
[2] Temple Univ, Sch Med, Dept Neurosci, Philadelphia, PA 19122 USA
关键词
D O I
10.2174/138161207782023766
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Integrins alpha(1)beta(1) and alpha(2)beta(1) are highly expressed oil the microvascular endothelial cells, and blocking of their adhesive properties significantly reduced the VEGF-driven neovascularization ratio and tumor growth in animal models. Hence, inhibitors of the alp, and alpha(2)beta(1) integrins, alone or in combination with antagonists of other integrins involved in angiogenesis (eg. a(v)beta(3), alpha(v)beta(5), and alpha(6)beta(4)), may prove benefitial in the control of tumor neovascularization. Viperidae snakes have developed in their venoms an efficient arsenal of integrin receptor antagonists. KTS- (obtustatin, viperistatin, lebestatin) and RTS- (jerdostatin) disintegrins represent viper venom peptides that specifically block the interaction of the alpha(1)beta(1) integrin with collagens IV and I in vitro and angiogenesis in vivo. The possible therapeutic approach towards tumor neovascularization by targeting the alpha(5)beta(1), alpha(v)beta(5) and alpha(v)beta(3) integrins with RGD-bearing disintegrins has been explored in a number of laboratories. Here we discuss structure-function correlations of the novel group of specific (K/R)TS-disintegrins targeting the alpha(1)beta(1) integrin.
引用
收藏
页码:2853 / 2859
页数:7
相关论文
共 66 条
[1]   Targeting integrins for the control of tumour angiogenesis [J].
Akalu, A ;
Cretu, A ;
Brooks, PC .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2005, 14 (12) :1475-1486
[2]   Vascular integrins in tumor angiogenesis:: Mediators and therapeutic targets [J].
Alghisi, Gian Carlo ;
Rueegg, Curzio .
ENDOTHELIUM-JOURNAL OF ENDOTHELIAL CELL RESEARCH, 2006, 13 (02) :113-135
[3]   Crystal structure of the disintegrin heterodimer from saw-scaled viper (Echis carinatus) at 1.9 Å resolution [J].
Bilgrami, S ;
Yadav, S ;
Kaur, P ;
Sharma, S ;
Perbandt, M ;
Betzel, C ;
Singh, TP .
BIOCHEMISTRY, 2005, 44 (33) :11058-11066
[4]   Crystal structure of schistatin, a disintegrin homodimer from saw-scaled viper (Echis carinatus) at 2.5 Å resolution [J].
Bilgrami, S ;
Tomar, S ;
Yadav, S ;
Kaur, P ;
Kumar, J ;
Jabeen, T ;
Sharma, S ;
Singh, TP .
JOURNAL OF MOLECULAR BIOLOGY, 2004, 341 (03) :829-837
[5]   Snake venom disintegrins:: evolution of structure and function [J].
Calvete, JJ ;
Marcinkiewicz, C ;
Monleón, D ;
Esteve, V ;
Celda, B ;
Juárez, P ;
Sanz, L .
TOXICON, 2005, 45 (08) :1063-1074
[6]   Structure-function correlations of snake venom disintegrins [J].
Calvete, JJ .
CURRENT PHARMACEUTICAL DESIGN, 2005, 11 (07) :829-835
[7]   Snake venom disintegrins: novel dimeric disintegrins and structural diversification by disulphide bond engineering [J].
Calvete, JJ ;
Moreno-Murciano, MP ;
Theakston, RDG ;
Kisiel, DG ;
Marcinkiewicz, C .
BIOCHEMICAL JOURNAL, 2003, 372 :725-734
[8]   Disulphide-bond pattern and molecular modelling of the dimeric disintegrin EMF-10, a potent and selective integrin α5β1 antagonist from Eristocophis macmahoni venom [J].
Calvete, JJ ;
Jürgens, M ;
Marcinkiewicz, C ;
Romero, A ;
Schrader, M ;
Niewiarowski, S .
BIOCHEMICAL JOURNAL, 2000, 345 :573-581
[9]   Peptide-based molecules in angiogenesis [J].
D'Andrea, LD ;
Del Gatto, A ;
Pedone, C ;
Benedetti, E .
CHEMICAL BIOLOGY & DRUG DESIGN, 2006, 67 (02) :115-126
[10]   Review - Proteases, extracellular matrix, and cancer - A workshop of the path B study section [J].
DeClerck, YA ;
Mercurio, AM ;
Stack, MS ;
Chapman, HA ;
Zutter, MM ;
Muschel, RJ ;
Raz, A ;
Matrisian, LM ;
Sloane, BF ;
Noel, A ;
Hendrix, MJ ;
Coussens, L ;
Padarathsingh, M .
AMERICAN JOURNAL OF PATHOLOGY, 2004, 164 (04) :1131-1139